BMY

Recent Articles

4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY

Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside? More 

The 5 Best Mutual Funds to Buy for 2016

Nailing down the best mutual funds for 2016 was no easy task but we found five that could be top performers. More 

GSK, BMY: GlaxoSmithKline to Buy Bristol-Myers HIV Drug

GlaxoSmithKline (NYSE:GSK) is buying HIV drugs produced by Bristol-Myers (NYSE:BMY). The Bristol-Myers medication will cost GlaxoSmithKline up to $1.5 billion, making it an even stronger U.K. pharmaceutical giant. The company will shell out $317 million upfront for the drugs, which treat late-stage HIV. An additional $518 million will be paid depending on particular development and... More 

Bristol-Myers Squibb Tops 12 Dividend Stocks Increasing Payouts

The list of dividend stocks increasing payouts included several pharmaceutical giants, a power generator and a credit card issuer. More 

5 Stocks to Buy for December

Looking for a few stocks to buy to ride December's usual upswing? Try these winners that boast strong seasonality and promising charts. More 

5 Big Pharma Stocks to Buy (And 2 Busts to Avoid!)

Several Big Pharma names are worthy buys right now, but a couple of pharmaceutical stocks may be best left avoided. More 

10 Pharmaceutical Stocks to Buy for the Dividends

Surprise! This sliver of the healthcare sector not known for dishing out income serves up some decent dividend stocks. More